source
- AstraZeneca halts late-stage trial of volrustomig in metastatic lung cancerAstraZeneca said it is stopping a late-stage study of its experimental drug volrustomig combined with chemotherapy in patients with metastatic non-small cell lung cancer. The company made the decis…
- Epic faces antitrust lawsuits and internal AI strategy turmoil ahead of annual user meetingEpic Systems, founded by Judy Faulkner, dominates the U.S. hospital electronic health record market and convenes its annual User Group Meeting with more than 20,000 attendees. The upcoming gatheri…